Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Investigational mineralocorticoid receptor antagonist KBP-5074 evaluated in phase I trial

Nov. 17, 2017

Achillion reports preliminary data from phase II study of ACH-4471 in C3G

Nov. 15, 2017

TP-0469711 demonstrates promising activity as a new therapeutic for hyperphosphatemia

Nov. 14, 2017

Novel antibody against TGF-beta1 shows efficacy without cardiotoxicity in fibrosis model

Nov. 14, 2017

Wound healing improved with SNF-472 in hemodialysis patients with calciphylaxis

Nov. 13, 2017

FDA accepts Otsuka's resubmitted NDA for tolvaptan

Nov. 10, 2017

FDA approves Keryx's Auryxia in new indication

Nov. 8, 2017

FDA gives orphan status to Achillion's ACH-4471 for PNH

Nov. 8, 2017

Klotho Therapeutics announces series A financing to advance patent pending version of Klotho

Nov. 7, 2017

Ono Pharmaceutical divulges novel voltage-gated channel activators

Nov. 6, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...